Diversis Capital Portfolio Company Caligor Opco, LLC Completes Acquisition of The Coghlan Group, Inc.

Represented Diversis Capital, LLC portfolio company, Caligor Opco, LLC in connection with its acquisition of all of the shares of The Coghlan Group, Inc., a Texas corporation. Financial terms of the transaction were not disclosed. 

Caligor Opco, LLC is a premier pharmaceutical and biotechnology services company specializing in the sourcing, distribution and storage of comparator drugs for clinical trials worldwide as well as a leading provider of unique and differentiated high touch unlicensed medicines for expanded access programs. The Coghlan Group, Inc. is a leading materials management service company for clinical trials.